Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation-Reference-Cited by-同舟云学术

Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation

Published:2017-11-06 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zgair Atheer,Lee Jong Bong,Wong Jonathan C. M.^ORCID,Taha Dhiaa A.,Aram Jehan,Di Virgilio Daisy,McArthur Joshua W.,Cheng Yu-Kit,Hennig Ivo M.,Barrett David A.^ORCID,Fischer Peter M.,Constantinescu Cris S.,Gershkovich Pavel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-15026-z.pdf

Reference56 articles.

1. Pertwee, R. G. Pharmacological and therapeutic targets for Δ9 tetrahydrocannabinol and cannabidiol. Euphytica 140, 73–82 (2004).

2. Katchan, V., David, P. & Shoenfeld, Y. Cannabinoids and autoimmune diseases: A systematic review. Autoimmunity reviews 15, 513–528, https://doi.org/10.1016/j.autrev.2016.02.008 (2016).

3. Kozela, E. et al. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br. J. Pharmacol. 163, 1507–1519, https://doi.org/10.1111/j.1476-5381.2011.01379.x (2011).

4. Malfait, A. M. et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 97, 9561–9566, https://doi.org/10.1073/pnas.160105897 (2000).

5. Weiss, L. et al. Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Neuropharmacology 54, 244–249, https://doi.org/10.1016/j.neuropharm.2007.06.029 (2008).

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-inflammatory effects of phytocannabinoids and terpenes on inflamed Tregs and Th17 cells in vitro;Experimental and Molecular Pathology;2024-10

2. Comparative Study of Gas and Liquid Chromatography Methods for the Determination of Underivatised Neutral and Acidic Cannabinoids and Cholesterol;Molecules;2024-05-07

3. The Chimera of TPGS and Nanoscale Lipid Carriers as Lymphatic Drug Delivery Vehicles to Fight Metastatic Cancers;Current Drug Delivery;2024-05

4. Cannabidiol Bioavailability Is Nonmonotonic with a Long Terminal Elimination Half-Life: A Pharmacokinetic Modeling-Based Analysis;Cannabis and Cannabinoid Research;2024-04-16

5. Antibiofilm and Immune-Modulatory Activity of Cannabidiol and Cannabigerol in Oral Environments—In Vitro Study;Antibiotics;2024-04-09